Stay Ahead of Compliance with Monthly Citation Updates


In your State Survey window and need a snapshot of your risks?

Survey Preparedness Report

One Time Fee
$79
  • Last 12 months of citation data in one tailored report
  • Pinpoint the tags driving penalties in facilities like yours
  • Jump to regulations and pathways used by surveyors
  • Access to your report within 2 hours of purchase
  • Easily share it with your team - no registration needed
Get Your Report Now →

Monthly citation updates straight to your inbox for ongoing preparation?

Monthly Citation Reports

$18.90 per month
  • Latest citation updates delivered monthly to your email
  • Citations organized by compliance areas
  • Shared automatically with your team, by area
  • Customizable for your state(s) of interest
  • Direct links to CMS documentation relevant parts
Learn more →

Save Hours of Work with AI-Powered Plan of Correction Writer


One-Time Fee

$49 per Plan of Correction
Volume discounts available – save up to 20%
  • Quickly search for approved POC from other facilities
  • Instant access
  • Intuitive interface
  • No recurring fees
  • Save hours of work
F0761
D

Medications Stored Above Manufacturer-Recommended Temperature

Upland, California Survey Completed on 05-09-2025

Penalty

No penalty information released
tooltip icon
The penalty, as released by CMS, applies to the entire inspection this citation is part of, covering all citations and f-tags issued, not just this specific f-tag. For the complete original report, please refer to the 'Details' section.

Summary

Surveyors found that the facility failed to store medications at the appropriate temperature in one of three medication rooms, specifically the Station 2 Medication Room. The daily temperature log showed that the room temperature reached 78°F on two consecutive days, exceeding the maximum storage temperature of 77°F indicated on the product labeling for several medications. During an inspection, multiple medications, including acetaminophen, senna syrup, loperamide, and docusate sodium, were observed stored in this room. The Assistant Director of Nursing confirmed that the product labels required storage at or below 77°F. A review of the facility's policy on medication storage, approved in January 2025, stated that medications and biologicals must be stored safely and according to manufacturer recommendations. The Director of Nursing acknowledged this policy during the interview and record review. The failure to maintain the required storage temperature for these medications constituted a deficiency in following both manufacturer guidelines and facility policy.

An unhandled error has occurred. Reload 🗙